<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02941471</url>
  </required_header>
  <id_info>
    <org_study_id>StMarksHF</org_study_id>
    <nct_id>NCT02941471</nct_id>
  </id_info>
  <brief_title>Transabdominal Electrical Stimulation for Constipation</brief_title>
  <official_title>A Double-blind Pilot Randomised Trial of Transabdominal Interferential Stimulation and Transcutaneous Electrical Nerve Stimulation for Severe Chronic Constipation in Adults Unresponsive to Conservative Treatments</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St Mark's Hospital Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St Mark's Hospital Foundation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Several transabdominal electrical stimulation studies have been reported for constipation in&#xD;
      childhood. This study aims to assess the efficacy of this technique in adults with chronic&#xD;
      constipation and compare two different electrical therapies.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with Rome III defined constipation unresponsive to medical and behavioural treatment&#xD;
      will be randomised in a double-blind prospective trial to receive either four weeks of&#xD;
      transabdominal electrical stimulation (TENS) or Interferential stimulation (IFC). Treatment&#xD;
      will be self-administered at home for sixty minutes a day. The response to treatment will be&#xD;
      assessed with the Patient Assessment of Constipation Quality of Life questionnaire (PAC-QOL),&#xD;
      the Patient-Assessment of Constipation Symptoms (PAC-SYM) tool and a bowel visual analogue&#xD;
      scale (VAS). A bowel diary will be kept a week before and during the final week of&#xD;
      stimulation, recording daily bowel frequency.&#xD;
&#xD;
      IFC stimulation is an effective, cheap and low risk intervention which has demonstrated&#xD;
      efficacy for dysphagia, urinary incontinence, overactive bladder syndromes and chronic pain.&#xD;
      The precise mechanism of its analgesic and pro-kinetic effect is unknown. The intervention is&#xD;
      delivered by two separate continuous alternating electrical currents. Two pairs of pad&#xD;
      electrodes are arranged in a quadripolar manner where each pair delivers a different&#xD;
      frequency of current. It is suggested that this arrangement of stimulation improves colonic&#xD;
      propagation. However as direct massage of the abdomen has demonstrated benefit in&#xD;
      constipation it is argued that IFC is not a specific requirement and that non-IFC electrical&#xD;
      stimulation over the abdomen is sufficient to evoke the same colonic and clinical responses.&#xD;
      Owing to these questions the efficacy of this intervention will be further evaluated in&#xD;
      adults.&#xD;
&#xD;
      This study has two aims. The primary aim is to evaluate the effectiveness of transabdominal&#xD;
      electrical nerve stimulation (TENS) in adult patients with chronic constipation. The&#xD;
      secondary aim is to establish whether IFC was superior to non-IFC (TENS) electrical&#xD;
      stimulation in adults with chronic constipation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">November 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient Assessment of Constipation Quality of Life questionnaire (PAC-QOL)</measure>
    <time_frame>After 4 weeks of stimulation</time_frame>
    <description>A validated tool for constipation severity assessment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient-Assessment of Constipation Symptoms (PAC-SYM)</measure>
    <time_frame>After 4 weeks of stimulation</time_frame>
    <description>A validated tool for constipation severity assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>A bowel visual analogue scale</measure>
    <time_frame>After 4 weeks of stimulation</time_frame>
    <description>a bowel visual analogue scale (0-100 where 0= 'very unhappy' 100= 'very happy') based on patients' response to the question 'how happy are you with the way your bowel has been functioning'</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weekly bowel and laxative diary</measure>
    <time_frame>one week and 4 weeks of stimulation</time_frame>
    <description>Standard bowel and laxative diary</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Constipation</condition>
  <arm_group>
    <arm_group_label>Interferential Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Medical Device: Interferential stimulation. Stimulation parameters: 4 KHz of carrier stimulation, beat frequency between 80-160Hz, amplitude upto 33mA. Delivered via two 100mm x 50mm adhesive pads placed on the anterior abdominal wall</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard electrical stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Medical Device: Standard electrical stimulation. Parameters set to provide continuous electrical stimulation at a pulse width of 210µs and a frequency of 14Hz and an amplitude upto 33mA.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Interferential Stimulation</intervention_name>
    <description>Transabdominal interferential electrcial stimulation</description>
    <arm_group_label>Interferential Stimulation</arm_group_label>
    <other_name>NeuroTrac® IFC Rehab device (Verity Medical Ltd, UK).</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TENS stimulation</intervention_name>
    <description>Transabdominal standard electrical stimulation</description>
    <arm_group_label>Standard electrical stimulation</arm_group_label>
    <other_name>NeuroTrac® Continence device (Verity Medical Ltd, UK).</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age over 18 years&#xD;
&#xD;
          -  Rome III defined constipation (frequency of defecation of less than three times a&#xD;
             week, straining or sense of incomplete emptying associated with at least 25% of&#xD;
             defecations. Lumpy, hard stools or anal digitation for at least 25% of defecations&#xD;
&#xD;
          -  Failed Biofeedback&#xD;
&#xD;
          -  Competent and willing to complete stimulation at home&#xD;
&#xD;
          -  Competent and willing to complete the questionnaires and bowel diaries&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Rectal prolapse&#xD;
&#xD;
          -  Active inflammatory bowel disease&#xD;
&#xD;
          -  Pregnancy or intention to become pregnant during trial&#xD;
&#xD;
          -  Spinal cord injuries/cauda equina syndrome&#xD;
&#xD;
          -  Other implanted electrical devices&#xD;
&#xD;
          -  Allergy to device components&#xD;
&#xD;
          -  Neurological disorders&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alan Warnes, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>The London Northwest Healthcare NHS Trust</affiliation>
  </overall_official>
  <verification_date>October 2016</verification_date>
  <study_first_submitted>October 18, 2016</study_first_submitted>
  <study_first_submitted_qc>October 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2016</study_first_posted>
  <last_update_submitted>October 20, 2016</last_update_submitted>
  <last_update_submitted_qc>October 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St Mark's Hospital Foundation</investigator_affiliation>
    <investigator_full_name>Fareed Iqbal</investigator_full_name>
    <investigator_title>Clinical Research Fellow/PI</investigator_title>
  </responsible_party>
  <keyword>Constipation</keyword>
  <keyword>Neuromodulation</keyword>
  <keyword>Interferential</keyword>
  <keyword>Transabdominal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>October 12, 2017</submitted>
    <returned>July 20, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

